WHO ICTRP trial
Effect of Kokilaksh and Musta in Gathiya (Rheumatoid Arthritis)
CTRI/2024/06/068485 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2024/06/068485 |
|---|---|
| Public title | Effect of Kokilaksh and Musta in Gathiya (Rheumatoid Arthritis) |
| Scientific title | A Pharmacognostical and Clinical study of Kokilaksh (Asteracantha longifolia Nees.) and Mustak (Cyperus rotundus Linn.) in Amavata W.S.R to Rheumatoid arthritis. - Nil |
| Primary sponsor | Madan Mohan Malaviya Government Ayurveda College |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement |
| Registration date | Jun 6, 2024 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: